Stay updated on 4D-125 in XLRP Patients Clinical Trial
Sign up to get notified when there's something new on the 4D-125 in XLRP Patients Clinical Trial page.

Latest updates to the 4D-125 in XLRP Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has undergone significant updates regarding the clinical trial for the gene therapy 4D-125 for X-linked Retinitis Pigmentosa, including changes to the trial's structure and participant criteria. Notably, the previous version's detailed descriptions of the study phases and inclusion/exclusion criteria have been removed, while new information about the trial's design and patient enrollment has been added.SummaryDifference35%
- Check36 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 21, 2025.SummaryDifference0.3%
- Check51 days agoChange DetectedThe page has updated the number of study locations from 7 to 8 and added specific details about a location in Salt Lake City, Utah. Additionally, the last update date has been changed to March 2025.SummaryDifference2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check94 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
Stay in the know with updates to 4D-125 in XLRP Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 4D-125 in XLRP Patients Clinical Trial page.